Protective Effect of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) on Liver Function: Results From MELD Analysis in Surgical Revascularization-A Preliminary Study

More on SGLT2 inhibitors

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026

• SGLT2 inhibitors raise genital but not urinary infection risk

  Clinical Pharmacology and Therapeutics · 4 Oct 2026

• Estimated sdLDL-C predicts cardiovascular risk in Japanese adults

  Journal of Clinical Lipidology · 4 Oct 2026

• Metabolic signature links frailty to coronary artery disease

  The Journal of Nutrition, Health & Aging · 4 Oct 2026